卡波西肉瘤相关疱疹病毒感染与地方性伯基特淋巴瘤
本研究通过多重血清学检测和PCR定量,分析了266例地方性伯基特淋巴瘤(eBL)患者、78例非eBL癌症患儿和202例健康儿童的KSHV、EBV及疟疾感染状况。发现KSHV血清阳性率在各组间无差异,但与年龄及抗疟疾抗体水平相关;KSHV载量在EBV病毒血症可检测的儿童中显著更低。结论认为KSHV-EBV双重感染不增加eBL风险,但EBV可能抑制KSHV再激活,而疟疾暴露与KSHV感染和/或再激活相关。
要点
- KSHV血清阳性率在eBL、非eBL癌症和健康儿童间无差异,但与年龄相关。
- KSHV血清阳性与抗疟疾抗体(AMA1、MSP1)水平显著相关。
- EBV病毒血症可检测的儿童中KSHV载量显著更低,提示EBV可能抑制KSHV再激活。
核心结论
- KSHV-EBV双重感染不增加地方性伯基特淋巴瘤风险。
- EBV可能抑制KSHV再激活,而疟疾暴露与KSHV感染和/或再激活相关。
- 在撒哈拉以南非洲,EBV和疟疾应被视为KSHV相关癌症的潜在效应修饰因素。
研究设计与样本
- 研究纳入266例eBL患者、78例非eBL癌症患儿和202例健康儿童。
- 采用多重血清学检测EBV、疟疾和KSHV抗体,并用PCR定量KSHV和EBV载量。
主要发现
- KSHV血清阳性率在各研究组间无差异,但与年龄相关。
- 以K8.1/LANA或联合其他5种KSHV抗原定义的血清阳性与抗AMA1抗体水平相关(OR 2.41,P < .001;OR 2.07,P < .001)。
- KSHV血清阳性与抗MSP1抗体水平相关(OR 2.41,P = .0006;OR 5.78,P < .001)。
- KSHV载量在各组间无差异,且与抗体水平不相关。
- 在EBV病毒血症可检测的儿童中,KSHV载量显著更低(P = .014)。
临床怎么用
- 在eBL高发区,评估KSHV相关癌症风险时需考虑疟疾暴露和EBV感染的交互作用。
- KSHV血清学阳性不能单独作为eBL风险标志,应结合疟疾抗体和EBV载量综合评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endemic Burkitt lymphoma (eBL) is associated with Epstein-Barr virus (EBV) and Plasmodium falciparum malaria coinfections. However, the role of Kaposi sarcoma-associated herpesvirus (KSHV), also endemic in Africa, has not been evaluated as a cofactor in eBL pathogenesis. METHODS: Multiplexed seroprofiles for EBV, malaria, and KSHV were generated for 266 eBL patients, 78 non-eBL cancers, and 202 healthy children. KSHV and EBV loads were quantified by PCR. RESULTS: KSHV seroprevalence did not differ by study group but was associated with age. Seropositivity, defined by K8.1/LANA or in combination with 5 other KSHV antigens (ORF59, ORF65, ORF61, ORF38, and K5) was associated with antimalarial antibody levels to AMA1 (odds ratio [OR], 2.41, P < .001; OR, 2.07, P < .001) and MSP1 (OR, 2.41, P = .0006; OR, 5.78, P < .001), respectively. KSHV loads did not correlate with antibody levels nor differ across groups but were significantly lower in children with detectable EBV viremia (P = .014). CONCLUSIONS: Although KSHV-EBV dual infection does not increase eBL risk, EBV appears to suppress reactivation of KSHV while malaria exposure is associated with KSHV infection and/or reactivation. Both EBV and malaria should, therefore, be considered as potential effect modifiers for KSHV-associated cancers in sub-Saharan Africa.
引用
- Oluoch PO, Oduor CI, Forconi CS, et al. Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma. J Infect Dis. 2020. PMID: 32072172. doi:10.1093/infdis/jiaa060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。